• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进展期胃体萎缩性胃炎患者幽门螺杆菌抗体的自发消失

Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis.

作者信息

Kokkola Arto, Kosunen Timo U, Puolakkainen Pauli, Sipponen Pentti, Harkonen Matti, Laxen Frank, Virtamo Jarmo, Haapiainen Reijo, Rautelin Hilpi

机构信息

Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland.

出版信息

APMIS. 2003 Jun;111(6):619-24. doi: 10.1034/j.1600-0463.2003.1110604.x.

DOI:10.1034/j.1600-0463.2003.1110604.x
PMID:12969017
Abstract

Background. Only a few reported studies focus on the natural history and course of advanced and severe chronic atrophic gastritis. Methods. In this study we followed 47 men (mean age 62 years) with advanced (moderate or severe) Helicobacter pylori-positive atrophic corpus gastritis. Duration of endoscopic follow-up was 6 years and follow-up based on serum levels of pepsinogen I and antibodies to H. pylori covered a period of 10 years. None of the patients was treated for H. pylori infection prior to end of follow-up. Results. The median H. pylori antibody titre declined (IgG from 4000 to 1300; IgA from 200 to 50) in the study population, and 11 men (23%) converted to seronegative (p=0.0005, Fisher's exact test). There was a small but significant (p=0.0004, Page's test) declining trend in mean atrophy score of the corpus during follow-up (from 2.5 to 2.2). However, no significant changes were observed in grade of atrophy or intestinal metaplasia of the antral mucosa or in grade of intestinal metaplasia in the corpus. The mean SPGI level remained at the initial low level during the entire follow-up. Conclusions. H. pylori antibodies disappear spontaneously within 10 years in almost one fourth of patients with advanced atrophic corpus gastritis. The disappearance of H. pylori antibodies is accompanied by no or more than a mild improvement of the gastric mucosa.

摘要

背景。仅有少数已发表的研究关注进展期和重度慢性萎缩性胃炎的自然病史和病程。方法。在本研究中,我们对47名男性(平均年龄62岁)进行了随访,这些男性患有进展期(中度或重度)幽门螺杆菌阳性的胃体萎缩性胃炎。内镜随访时间为6年,基于胃蛋白酶原I血清水平和幽门螺杆菌抗体的随访时间为10年。在随访结束前,所有患者均未接受幽门螺杆菌感染治疗。结果。研究人群中幽门螺杆菌抗体滴度中位数下降(IgG从4000降至1300;IgA从200降至50),11名男性(23%)转为血清学阴性(p=0.0005,Fisher精确检验)。随访期间胃体平均萎缩评分有小幅度但显著的下降趋势(p=0.0004,Page检验)(从2.5降至2.2)。然而,胃窦黏膜萎缩程度或肠化生程度以及胃体肠化生程度均未观察到显著变化。整个随访期间,血清胃蛋白酶原I水平维持在初始的低水平。结论。在几乎四分之一的进展期胃体萎缩性胃炎患者中,幽门螺杆菌抗体在10年内会自发消失。幽门螺杆菌抗体消失时,胃黏膜无改善或仅有轻微改善。

相似文献

1
Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis.进展期胃体萎缩性胃炎患者幽门螺杆菌抗体的自发消失
APMIS. 2003 Jun;111(6):619-24. doi: 10.1034/j.1600-0463.2003.1110604.x.
2
Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.萎缩性胃炎患者血清中酰胺化胃泌素-17和胃蛋白酶原I水平:一项观察性病例对照研究。
Scand J Gastroenterol. 2002 Jul;37(7):785-91.
3
Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.幽门螺杆菌状态与血清胃蛋白酶原作为萎缩性胃炎血清学标志物之间的关系
Turk J Gastroenterol. 2006 Sep;17(3):172-6.
4
The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia.幽门螺杆菌根除对伴发育异常的萎缩性胃炎自然病程的影响。
Aliment Pharmacol Ther. 2002 Mar;16(3):515-20. doi: 10.1046/j.1365-2036.2002.01214.x.
5
Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study.通过血液检测对萎缩性胃炎进行非内镜诊断。胃组织学与胃泌素-17和胃蛋白酶原I血清水平之间的相关性:一项多中心研究。
Eur J Gastroenterol Hepatol. 2003 Aug;15(8):885-91. doi: 10.1097/00042737-200308000-00009.
6
Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy.因胃镜检查而转诊的门诊患者中的萎缩性胃炎和幽门螺杆菌感染
Gut. 2000 Apr;46(4):460-3. doi: 10.1136/gut.46.4.460.
7
Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis.血清抗幽门螺杆菌IgG抗体及胃蛋白酶原A和C作为慢性萎缩性胃炎的血清学标志物。
Cancer Epidemiol Biomarkers Prev. 1993 Mar-Apr;2(2):119-23.
8
Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.幽门螺杆菌感染中的萎缩性胃炎和肠化生:细胞毒素相关基因A(CagA)状态的作用
Am J Gastroenterol. 1998 Mar;93(3):375-9. doi: 10.1111/j.1572-0241.1998.00375.x.
9
Helicobacter pylori and atrophic gastritis: importance of the cagA status.幽门螺杆菌与萎缩性胃炎:细胞毒素相关基因A(cagA)状态的重要性
J Natl Cancer Inst. 1995 Dec 6;87(23):1777-80. doi: 10.1093/jnci/87.23.1777.
10
Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.基于血清胃蛋白酶原和幽门螺杆菌抗体滴度评估的慢性活动性胃炎和由此导致的胃萎缩与癌症发展的关系。
Int J Cancer. 2014 Mar 15;134(6):1445-57. doi: 10.1002/ijc.28470. Epub 2013 Oct 3.

引用本文的文献

1
Calibrating multiplex serology for Helicobacter pylori.校准幽门螺杆菌多重血清学检测方法
Diagn Progn Res. 2025 Aug 11;9(1):17. doi: 10.1186/s41512-025-00202-x.
2
Increasing our knowledge about the epidemiology of in Nunavik's Inuit population (Québec, Canada) using 2017 cross-sectional survey.利用2017年横断面调查增加我们对努纳维克因纽特人群(加拿大魁北克)流行病学的了解。
Int J Circumpolar Health. 2024 Dec;83(1):2398864. doi: 10.1080/22423982.2024.2398864. Epub 2024 Sep 16.
3
Analyses of the association between antibody titre and pathogenicity before and after eradication: results of the Kyushu and Okinawa population study, a retrospective observational cohort study.
根除前后抗体滴度与致病性之间关联的分析:九州和冲绳人群研究结果,一项回顾性观察队列研究
BMJ Open. 2024 Aug 7;14(8):e083157. doi: 10.1136/bmjopen-2023-083157.
4
Clinical Characteristics of Patients With Previous Helicobacter pylori Infection-Induced Atrophic Gastritis.既往幽门螺杆菌感染所致萎缩性胃炎患者的临床特征
Cureus. 2024 Jun 28;16(6):e63368. doi: 10.7759/cureus.63368. eCollection 2024 Jun.
5
A novel predictive formula for highly accurate discrimination between truly Helicobacter pylori-uninfected and currently infected/spontaneously eradicated individuals for gastric cancer screening.一种用于高度准确区分真正幽门螺杆菌未感染和当前感染/自发根除个体的新型预测公式,用于胃癌筛查。
Medicine (Baltimore). 2024 Mar 1;103(9):e36335. doi: 10.1097/MD.0000000000036335.
6
Eradication Does Not Adversely Affect the Clinical Course of Gastric Cancer: A Multicenter Study on Screening Endoscopic Examination in Japan.根除治疗不会对胃癌的临床病程产生不利影响:日本一项关于筛查内镜检查的多中心研究
Cancers (Basel). 2024 Feb 9;16(4):733. doi: 10.3390/cancers16040733.
7
Trends in the prevalence of atrophic gastritis and Helicobacter pylori infection over a 10‑year period in Japan: The ROAD study 2005‑2015.日本萎缩性胃炎和幽门螺杆菌感染患病率在10年期间的变化趋势:2005 - 2015年ROAD研究
Mol Clin Oncol. 2023 May 19;19(1):53. doi: 10.3892/mco.2023.2649. eCollection 2023 Jul.
8
Long-term Response of Helicobacter pylori Antibody Titer After Eradication Treatment in Middle-aged Japanese: JPHC-NEXT Study.根治治疗后中老年日本人幽门螺杆菌抗体滴度的长期应答:JPHC-NEXT 研究。
J Epidemiol. 2023 Jan 5;33(1):1-7. doi: 10.2188/jea.JE20200618. Epub 2021 Oct 19.
9
Prediction of true Helicobacter pylori-uninfected status using a combination of age, serum antibody and pepsinogen: Logistic regression analysis.基于年龄、血清抗体和胃蛋白酶原联合预测真正的幽门螺杆菌感染状态:Logistic 回归分析。
PLoS One. 2020 Oct 1;15(10):e0240040. doi: 10.1371/journal.pone.0240040. eCollection 2020.
10
Serum Anti-Helicobacter pylori IgG Antibody Titer in H. pylori-negative Cases with a Different Gastric Mucosal Atrophy Status.血清抗幽门螺杆菌 IgG 抗体滴度在幽门螺杆菌阴性伴不同胃黏膜萎缩状态的病例中。
Intern Med. 2020 Nov 15;59(22):2817-2823. doi: 10.2169/internalmedicine.5132-20. Epub 2020 Jul 21.